Last Updated:
NameDesignationAppointment DateStatus
Chetan Doshi Mansukhlal

Appointed as Director since December 2019

Director27-Dec-2019Current
Pravin Gangadhar Sonawane

Appointed as Director since September 2024

Director09-Sep-2024Current
Vishal Narindernath Mehra

Appointed as Director since July 2012

Director20-Jul-2012Current
Vivek Gul Asrani

Appointed as Director since April 2005

Director01-Apr-2005Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Om Pharmaceuticals Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

People Timeline

Explore the timeline of key personnel in Om Pharmaceuticals Limited's leadership journey.

Loading...
Contact Details
  • Address 202, Vishwa Nanak Apartments Gurunanak Wadi, Chakala, Andheri (East), Mumbai Maharashtra, 400099, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Om Pharmaceuticals Limited through their registered address at 202, Vishwa Nanak Apartments Gurunanak Wadi, Chakala, Andheri (East), Mumbai Maharashtra, 400099, India, or via their website at sdlindia.com. Social media links are also provided where applicable.
The current directors of Om Pharmaceuticals Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • CHETAN DOSHI MANSUKHLAL
  • VIVEK GUL ASRANI
  • VISHAL NARINDERNATH MEHRA
  • Pravin Gangadhar Sonawane
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available